Abstract
Purpose
Perfluoroalkyl substances (PFAS) are a class of endocrine-disrupting chemicals. Toxicological studies indicate that PFAS accumulate in bone tissue and could cause alterations in bone metabolism. The primary objective of this study was to examine the association between PFAS exposure and bone status in a cohort of young men resident in a well-defined area with high PFAS environmental pollution.
Methods
Bone status was assessed in 117 subjects aged 18–21 by quantitative ultrasound (QUS) at the heel. Subjects underwent an accurate medical visit. Socio-demographic characteristics, lifestyle, and medical histories were collected. We also verified the interaction between PFAS and hydroxyapatite by computational modelling. The organic anion-transporting peptide (OATP), the putative transporter of PFAS, was evaluated by qPCR in bone biopsies from femoral heads discarded during arthroplasty in three male subjects.
Results
Exposed subjects showed significantly lower stiffness index, which resulted in lower t-score and higher prevalence of subjects at medium-high risk of fracture (23.6%) compared with controls (9.7%). Data from computational modelling suggested that PFOA exhibits a high affinity for hydroxyapatite, since the estimated change in free energy is in the order of that exhibited by bisphosphonates. Finally, we observed consistent expression of OATP1A2 gene in primary human osteoblasts.
Conclusions
This is the first study reporting increased osteoporosis risk in young men exposed to PFAS and provide preliminary information on molecular mechanisms that could explain this observation, in agreement with previous studies on animal models and humans. However, these results must be interpreted with caution given the cross-sectional study design and the small number of cases.
Similar content being viewed by others
References
J.M. Conder, R.A. Hoke, W. De Wolf, M.H. Russell, R.C. Buck, Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ. Sci. Technol. 42, 995–1003 (2008)
G.W. Olsen, C.C. Lange, M.E. Ellefson, D.C. Mair, T.R. Church, C.L. Goldberg, R.M. Herron, Z. Medhdizadehkashi, J.B. Nobiletti, J.A. Rios, W.K. Reagen, L.R. Zobel, Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000–2010. Environ. Sci. Technol. 46, 6330–6338 (2012). https://doi.org/10.1021/es300604p
C. Kubwabo, I. Kosarac, K. Lalonde, Determination of selected perfluorinated compounds and polyfluoroalkyl phosphate surfactants in human milk. Chemosphere 91, 771–7 (2013). https://doi.org/10.1016/j.chemosphere.2013.02.011
S. Kim, K. Choi, K. Ji, J. Seo, Y. Kho, J. Park, S. Kim, S. Park, I. Hwang, J. Jeon, H. Yang, J.P. Giesy, Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Environ. Sci. Technol. 45, 7465–7472 (2011). https://doi.org/10.1021/es202408a
C. Foresta, S. Tescari, A. Di Nisio, Impact of perfluorochemicals on human health and reproduction: a male’s perspective. J. Endocrinol. Investig. (2017). https://doi.org/10.1007/s40618-017-0790-z
A. Di Nisio, C. Foresta, Water and soil pollution as determinant of water and food quality/contamination and its impact on male fertility. Reprod. Biol. Endocrinol. 17, 4 (2019). https://doi.org/10.1186/s12958-018-0449-4
A. Koskela, M.A. Finnilä, M. Korkalainen, S. Spulber, J. Koponen, H. Håkansson, J. Tuukkanen, M. Viluksela, Effects of developmental exposure to perfluorooctanoic acid (PFOA) on long bone morphology and bone cell differentiation. Toxicol. Appl. Pharmacol. 301, 14–21 (2016). https://doi.org/10.1016/j.taap.2016.04.002
L.Y. Lin, L.L. Wen, T.C. Su, P.C. Chen, C.Y. Lin, Negative association between serum perfluorooctane sulfate concentration and bone mineral density in US premenopausal women: NHANES, 2005–2008. J. Clin. Endocrinol. Metab. 99, 2173–2180 (2014). https://doi.org/10.1210/jc.2013-3409
N. Khalil, A. Chen, M. Lee, S.A. Czerwinski, J.R. Ebert, J.C. De Witt, K. Kannan, Association of perfluoroalkyl substances, bone mineral density, and osteoporosis in the U.S. population in NHANES 2009–2010. Environ. Health Perspect. 124, 81–87 (2016). https://doi.org/10.1289/ehp.1307909
N. Khalil, J.R. Ebert, M. Honda, M. Lee, R.W. Nahhas, A. Koskela, T. Hangartner, K. Kannan, Perfluoroalkyl substances, bone density, and cardio-metabolic risk factors in obese 8–12 year old children: a pilot study. Environ. Res. 160, 314–321 (2018). https://doi.org/10.1016/j.envres.2017.10.014
Z. Jeddy, J.H. Tobias, E.V. Taylor, K. Northstone, W.D. Flanders, T.J. Hartman, Prenatal concentrations of perfluoroalkyl substances and bone health in British girls at age 17. Arch. Osteoporos. 13, (2018). https://doi.org/10.1007/s11657-018-0498-5
J. Bogdanska, D. Borg, M. Sundström, U. Bergström, K. Halldin, M. Abedi-Valugerdi, Å. Bergman, B. Nelson, J. DePierre, S. Nobel, Tissue distribution of 35S-labelled perfluorooctane sulfonate in adult mice after oral exposure to a low environmentally relevant dose or a high experimental dose. Toxicology 284, 54–62 (2011). https://doi.org/10.1016/j.tox.2011.03.014
F. Pérez, M. Nadal, A. Navarro-Ortega, F. Fàbrega, J.L. Domingo, D. Barceló, M. Farré, Accumulation of perfluoroalkyl substances in human tissues. Environ. Int. 59, 354–362 (2013). https://doi.org/10.1016/j.envint.2013.06.004
A. Koskela, J. Koponen, P. Lehenkari, M. Viluksela, M. Korkalainen, J. Tuukkanen, Perfluoroalkyl substances in human bone: concentrations in bones and effects on bone cell differentiation. Sci. Rep. 7, 6841 (2017). https://doi.org/10.1038/s41598-017-07359-6
A. Di Nisio, I. Sabovic, U. Valente, S. Tescari, M.S. Rocca, D. Guidolin, S. Dall’Acqua, L. Acquasaliente, N. Pozzi, M. Plebani, A. Garolla, C. Foresta, Endocrine disruption of androgenic activity by perfluoroalkyl substances: clinical and experimental evidence. J. Clin. Endocrinol. Metab. 104, 1259–1271 (2019). https://doi.org/10.1210/jc.2018-01855
Y.M. Weaver, D.J. Ehresman, J.L. Butenhoff, B. Hagenbuch, Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths. Toxicol. Sci. 113, 305–314 (2010). https://doi.org/10.1093/toxsci/kfp275
N.E. Skakkebaek, E. Rajpert-De Meyts, K.M. Main, Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16, 972–8 (2001)
Veneto Region. Regional Council Resolution, D.G.R. 2133/2016, Annex A and subsequent modifications. (2016). Available at: https://bur.regione.veneto.it/BurvServices/pubblica/DettaglioDgr.aspx?id=336975
M.-A. Krieg, R. Barkmann, S. Gonnelli, A. Stewart, D.C. Bauer, L. Del Rio Barquero, J.J. Kaufman, R. Lorenc, P.D. Miller, W.P. Olszynski, C. Poiana, A.-M. Schott, E.M. Lewiecki, D: Hans, Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions. J. Clin. Densitom. 11, 163–187 (2008). https://doi.org/10.1016/j.jocd.2007.12.011
R.M. Berg, H. Wallaschofski, M. Nauck, R. Rettig, M.R.P. Markus, R. Laqua, N. Friedrich, A. Hannemann, Positive association between adipose tissue and bone stiffness. Calcif. Tissue Int. 97, 40–49 (2015). https://doi.org/10.1007/s00223-015-0008-3
S.L. Greenspan, M.L. Bouxsein, M.E. Melton, A.H. Kolodny, J.H. Clair, P.T. Delucca, M. Stek, K.G. Faulkner, E.S. Orwoll, Precision and discriminatory ability of calcaneal bone assessment technologies. J. Bone Miner. Res. 12, 1303–1313 (1997). https://doi.org/10.1359/jbmr.1997.12.8.1303
P. Hadji, O. Hars, C. Wüster, K. Bock, U.-S. Alberts, H.-G. Bohnet, G. Emons, K.-D. Schulz, Stiffness index identifies patients with osteoporotic fractures better than ultrasound velocity or attenuation alone. Maturitas 31, 221–226 (1999). https://doi.org/10.1016/S0378-5122(99)00003-1
M. Jaworski, M. Lebiedowski, R.S. Lorenc, J. Trempe, Ultrasound bone measurement in pediatric subjects. Calcif. Tissue Int. 56, 368–371 (1995). https://doi.org/10.1007/BF00301604
H. Heinz, T.-J. Lin, R. Kishore Mishra, F.S. Emami, Thermodynamically consistent force fields for the assembly of inorganic, organic, and biological nanostructures: the INTERFACE force field. Langmuir 29, 1754–1765 (2013). https://doi.org/10.1021/la3038846
O. Trott, A.J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–61 (2010). https://doi.org/10.1002/jcc.21334
A. Ferlin, L. Perilli, L. Gianesello, G. Taglialavoro, C. Foresta, Profiling insulin like factor 3 (INSL3) signaling in human osteoblasts. PLoS One. 6, (2011). https://doi.org/10.1371/journal.pone.0029733
K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–8 (2001). https://doi.org/10.1006/meth.2001.1262
L.F. Duarte, F.C. Teixeira, R. Fausto, Molecular modeling of the interaction of novel hydroxy- and aminobisphosphonates with hydroxyapatite. Arkivoc 2010, 117 (2009). https://doi.org/10.3998/ark.5550190.0011.512
J.R. Thibodeaux, R.G. Hanson, J.M. Rogers, B.E. Grey, B.D. Barbee, J.H. Richards, J.L. Butenhoff, L.A. Stevenson, C. Lau, Exposure to Perfluorooctane Sulfonate during Pregnancy in Rat and Mouse. I: Maternal and Prenatal Evaluations. Toxicol. Sci. 74, 369–381 (2003). https://doi.org/10.1093/toxsci/kfg121
A.M. Ingelido, A. Abballe, S. Gemma, E. Dellatte, N. Iacovella, G. De Angelis, F. Zampaglioni, V. Marra, R. Miniero, S. Valentini, F. Russo, M. Vazzoler, E. Testai, E. De Felip, Biomonitoring of perfluorinated compounds in adults exposed to contaminated drinking water in the Veneto Region, Italy. Environ. Int. 110, 149–159 (2018). https://doi.org/10.1016/j.envint.2017.10.026
E. Hernlund, A. Svedbom, M. Ivergård, J. Compston, C. Cooper, J. Stenmark, E.V. McCloskey, B. Jönsson, J.A. Kanis, Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch. Osteoporos. 8, 136 (2013). https://doi.org/10.1007/s11657-013-0136-1
G.I. Baroncelli, Quantitative ultrasound methods to assess bone mineral status in children: technical characteristics, performance, and clinical application. Pediatr. Res. 63, 220–228 (2008). https://doi.org/10.1203/PDR.0b013e318163a286
G. Alwis, B. Rosengren, J.Å. Nilsson, S. Stenevi-Lundgren, M. Sundberg, I. Sernbo, M.K. Karlsson, Normative calcaneal quantitative ultrasound data as an estimation of skeletal development in Swedish children and adolescents. Calcif. Tissue Int. 87, 493–506 (2010). https://doi.org/10.1007/s00223-010-9425-5
J. Schalamon, G. Singer, G. Schwantzer, Y. Nietosvaara, Quantitative ultrasound assessment in children with fractures. J. Bone Miner. Res. 19, 1276–1279 (2004). https://doi.org/10.1359/JBMR.040401
K.-Y. Chin, S. Ima-Nirwana, Calcaneal quantitative ultrasound as a determinant of bone health status: what properties of bone does it reflect? Int. J. Med. Sci. 10, 1778 (2013). https://doi.org/10.7150/IJMS.6765
B.K. Weeks, R. Hirsch, R.C. Nogueira, B.R. Beck, Is calcaneal broadband ultrasound attenuation a valid index of dual-energy x-ray absorptiometry-derived bone mass in children? Bone Jt. Res. 5, 538–543 (2016). https://doi.org/10.1302/2046-3758.511.BJR-2016-0116.R1
Y. Xu, B. Guo, J. Gong, H. Xu, Z. Bai, The correlation between calcaneus stiffness index calculated by QUS and total body BMD assessed by DXA in Chinese children and adolescents. J. Bone Miner. Metab. 32, 159–166 (2014). https://doi.org/10.1007/s00774-013-0474-5
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Di Nisio, A., De Rocco Ponce, M., Giadone, A. et al. Perfluoroalkyl substances and bone health in young men: a pilot study. Endocrine 67, 678–684 (2020). https://doi.org/10.1007/s12020-019-02096-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-019-02096-4